ABLYNX |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
ACHILLION |
26 000 |
0,46% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
RareConnect® |
8 000 |
0,14% |
Rare Diseases International |
8 000 |
0,14% |
ACTELION |
45 000 |
0,80% |
EURORDIS Black Pearl Awards |
35 000 |
0,63% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
AEGERION |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
AGIOS |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
AKCEA |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
ALEXION |
25 000 |
0,45% |
EURORDIS Membership Meeting |
15 000 |
0,27% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
ALNYLAM |
35 000 |
0,63% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
AMGEN |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
AMICUS THERAPEUTICS |
15 000 |
0,27% |
EURORDIS Black Pearl Awards |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
ASTRAZENECA |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
AUDENTES |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
AVEXIS |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
BAYER |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
BIOGEN |
52 862 |
0,94% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
EURORDIS Black Pearl Awards |
25 000 |
0,45% |
Rare Diseases International |
17 862 |
0,32% |
BIOMARIN |
30 000 |
0,54% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
Multistakeholders Symposium |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
BLUEBIRD BIO |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
BOEHRINGER INGELHEIM |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
BRISTOL-MYERS SQUIBB |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
CELGENE |
100 000 |
1,79% |
Multistakeholders Symposium |
25 000 |
0,45% |
EURORDIS International Initiatives |
35 000 |
0,63% |
EURORDIS Membership Meeting |
15 000 |
0,27% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
CHIESI |
40 000 |
0,72% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
EURORDIS Black Pearl Awards |
10 000 |
0,18% |
RareConnect® |
15 000 |
0,27% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
CLEMENTIA |
18 750 |
0,34% |
EURORDIS Black Pearl Awards |
20 000 |
0,36% |
Cutoff* |
-1 250 |
-0,02% |
CSL BEHRING |
78 500 |
1,40% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
EURORDIS International Initiatives |
20 000 |
0,36% |
EURORDIS Black Pearl Awards |
20 000 |
0,36% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
Cutoff* |
3 500 |
0,06% |
CYTOKINETICS |
30 000 |
0,54% |
EURORDIS Black Pearl Awards |
20 000 |
0,36% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
DOMPE |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
EDITAS |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
ENZYVANT |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
GRIFOLS |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
GSK |
70 000 |
1,25% |
Rare Barometer |
35 000 |
0,63% |
RareConnect® |
35 000 |
0,63% |
HELSINN |
15 000 |
0,27% |
Rare Cancers Joint Action |
15 000 |
0,27% |
HORIZON |
31 000 |
0,55% |
RareConnect® |
15 000 |
0,27% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
Cutoff* |
6 000 |
0,11% |
ICON |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
INCYTE |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
INSMED |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
IPSEN |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
JAZZ PHARMA |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
KYOWA KIRIN |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
LEADIANT BIOSCIENCES |
8 000 |
0,14% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
Cutoff* |
3 000 |
0,05% |
LFB BIOMEDICAMENTS |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
LYSOGENE |
2 000 |
0,04% |
EURORDIS Round Table of Companies |
2 000 |
0,04% |
MSD EUROPE |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
NOVARTIS |
80 000 |
1,43% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
RareConnect® |
20 000 |
0,36% |
Rare Diseases International |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
Rare Barometer |
15 000 |
0,27% |
ORPHAN EUROPE |
30 000 |
0,54% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
EURORDIS Black Pearl Awards |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
OVID THERAPEUTICS |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
PFIZER |
130 000 |
2,32% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
EURORDIS Membership Meeting |
15 000 |
0,27% |
Multistakeholders Symposium |
40 000 |
0,72% |
EURORDIS International Initiatives |
50 000 |
0,89% |
PHARMA MAR |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
PROMETIC LIFE SCIENCES |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
PTC |
35 000 |
0,63% |
EURORDIS Black Pearl Awards |
25 000 |
0,45% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
REGENXBIO |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
ROCHE |
45 000 |
0,80% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
EURORDIS Black Pearl Awards |
20 000 |
0,36% |
SANGAMO |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
SANOFI GENZYME |
60 000 |
1,07% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
EURORDIS Membership Meeting |
15 000 |
0,27% |
Rare Diseases International |
20 000 |
0,36% |
SANTHERA |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
SHIRE |
130 000 |
2,32% |
EURORDIS Black Pearl Awards |
50 000 |
0,89% |
International activities |
55 000 |
0,98% |
EURORDIS Round Table of Companies |
25 000 |
0,54% |
SOBI |
30 000 |
0,54% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
EURORDIS Black Pearl Awards |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
SPARK THERAPEUTICS |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
STALLERGENES GREER |
8 000 |
0,14% |
EURORDIS Black Pearl Awards |
8 000 |
0,14% |
SYNEOS HEALTH |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
TAKEDA |
42 896 |
0,77% |
EURORDIS International Initiatives |
32 896 |
0,59% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
UCB |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
ULTRAGENYX |
28 750 |
0,51% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
EURORDIS Black Pearl Awards |
25 000 |
0,45% |
Cutoff* |
-1 250 |
-0,02% |
VERTEX |
90 000 |
1,61% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
EURORDIS Membership Meeting |
10 000 |
0,18% |
Rare Barometer |
50 000 |
0,89% |
Rare Diseases International |
20 000 |
0,36% |
VIFOR PHARMA |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
WAVE LIFE SCIENCES |
10 000 |
0,18% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
Grand Total |
1 591 758 |
28,46% |
Other Health Sector Companies |
Company |
Amount (€) |
% of Revenue |
CYDAN II |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
CLINIGEN |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
MAPI |
28 147 |
0,50% |
EURORDIS Round Table of Companies |
10 000 |
0,18% |
Rare Barometer |
18 147 |
0,32% |
INCEPTUA |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
OPENAPP |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
QuintilesIMS-IQVIA |
25 000 |
0,45% |
EURORDIS Round Table of Companies |
25 000 |
0,45% |
VITRO SOFTWARE |
5 000 |
0,09% |
EURORDIS Round Table of Companies |
5 000 |
0,09% |
CLINIGEN |
10 000 |
0,18% |
EURORDIS Black Pearl Awards |
10 000 |
0,18% |
MK&A |
3 000 |
0,05% |
EURORDIS Black Pearl Awards |
3 000 |
0,05% |
Total |
100 189 |
1,79% |
|
|
|
Corporates Outside the Health Sector |
Company |
Amount (€) |
% of Revenue |
MICROSOFT |
15 000 |
0,27% |
Data management initiatives |
15 000 |
0,27% |
BURSON MARSTELLER |
5 000 |
0,09% |
Core activities |
5 000 |
0,09% |
DLA PIPER |
6 500 |
0,12% |
Core activities |
6 500 |
0,12% |
MEDIA PLANET |
14 225 |
0,25% |
Core activities |
14 225 |
0,25% |
GOOGLE |
5 963 |
0,11% |
Core activities |
5 963 |
0,11% |
PUBLICIS LIFEBRAND |
35 760 |
0,64% |
Rare Disease Day |
35 760 |
0,64% |
REFLEX MEDIA |
11 175 |
0,20% |
Core activities |
11 175 |
0,20% |
TRANSLATORS WITHOUT BORDERS |
3 048 |
0,04% |
RareConnect® |
3 048 |
0,05% |
TROMMONS |
3 048 |
0,05% |
RareConnect® |
3 048 |
0,05% |
MISCELLANEOUS |
439 |
0,01% |
Core activities |
439 |
0,01% |
Total |
100 189 |
1,79% |